Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-23 Purchase | 2021-03-24 7:21 pm | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 100,000 | $2.4818 | $248,180 | 180,426 (Direct) | View |
| 2020-11-24 Purchase | 2020-11-25 9:07 pm | Sio Gene Therapies Inc. | SIOX | Pande Atul Director | 10,000 | $2.3399 | $23,399 | 33,370 (Indirect) | View |
| 2020-07-08 Purchase | 2020-07-10 6:12 pm | Axovant Gene Therapies Ltd. | AXGT | Pande Atul Director | 10,000 | $2.729 | $27,290 | 23,370 (Indirect) | View |
| 2020-07-08 Purchase | 2020-07-10 6:11 pm | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer | 37,500 | $2.737 | $102,638 | 57,836 (Direct) | View |
| 2020-03-16 Purchase | 2020-03-18 8:20 pm | Axovant Gene Therapies Ltd. | AXGT | Pande Atul Director | 10,000 | $1.7844 | $17,844 | 13,370 (Indirect) | View |
| 2020-02-24 Purchase | 2020-02-27 7:49 pm | Axovant Gene Therapies Ltd. | AXGT | Roivant Sciences Ltd. 10% Owner | 5,333,333 | $3.75 | $19,999,999 | 18,577,380 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-08 Option Award | 2022-02-10 5:07 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Meswani Parag V Chief Commercial Officer | 153,700 | $0 | 153,700 (Direct) | View |
| 2022-02-08 Option Award | 2022-02-10 5:05 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Interim CEO, CFO | 546,500 | $0 | 546,500 (Direct) | View |
Ownership | 2022-02-07 7:17 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Meswani Parag V Chief Commercial Officer | 0 | $0 | 368,799 (Direct) | View |
| 2021-12-08 Tax Withholding | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 6,294 | $1.42 | 80,310 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 17,534 | $0 | 80,310 (Direct) | View |
| 2021-12-08 Disposition | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 17,534 | $0 | 80,310 (Direct) | View |
| 2021-12-08 Tax Withholding | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 14,884 | $1.42 | 278,242 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 37,567 | $0 | 278,242 (Direct) | View |
| 2021-12-08 Disposition | 2021-12-09 6:31 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 37,567 | $0 | 278,242 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:59 pm | N/A 2031-04-14 | Sio Gene Therapies Inc. | SIOX | Vuori Kristiina MD Director | 42,000 | $0 | 42,000 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:57 pm | N/A 2031-04-14 | Sio Gene Therapies Inc. | SIOX | Torti Frank Director | 42,000 | $0 | 42,000 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:56 pm | N/A 2031-04-14 | Sio Gene Therapies Inc. | SIOX | Sundaram Senthil Vel Director | 42,000 | $0 | 42,000 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:55 pm | N/A 2031-04-14 | Sio Gene Therapies Inc. | SIOX | Pande Atul Director | 42,000 | $0 | 42,000 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:54 pm | N/A 2031-04-14 | Sio Gene Therapies Inc. | SIOX | Modig Berndt Director | 42,000 | $0 | 42,000 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:53 pm | N/A 2031-04-14 | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 239,000 | $0 | 239,000 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:52 pm | N/A 2031-04-14 | Sio Gene Therapies Inc. | SIOX | Corcoran Gavin Chief R&D Officer | 244,300 | $0 | 244,300 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:51 pm | N/A 2031-04-14 | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 682,100 | $0 | 682,100 (Direct) | View |
| 2021-03-22 Option Award | 2021-03-22 9:25 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 15,060 | $0 | 34,004 (Direct) | View |
| 2021-03-22 Disposition | 2021-03-22 9:25 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer | 15,060 | $0 | 34,004 (Direct) | View |
| 2021-03-17 Option Award | 2021-03-19 4:58 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Corcoran Gavin Chief R&D Officer | 16,001 | $0 | 25,792 (Direct) | View |
| 2021-03-17 Disposition | 2021-03-19 4:58 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Corcoran Gavin Chief R&D Officer | 16,001 | $0 | 25,792 (Direct) | View |
| 2021-03-17 Option Award | 2021-03-19 4:55 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 22,590 | $0 | 80,426 (Direct) | View |
| 2021-03-17 Disposition | 2021-03-19 4:55 pm | N/A N/A | Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer | 22,590 | $0 | 80,426 (Direct) | View |
| 2020-10-05 Option Award | 2020-10-07 9:28 pm | N/A 2030-10-04 | Axovant Gene Therapies Ltd. | AXGT | Vuori Kristiina MD Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2020-06-11 Tax Withholding | 2020-06-15 7:40 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 5,266 | $3.25 | 34,004 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 7:40 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 15,060 | $0 | 34,004 (Direct) | View |
| 2020-06-12 Disposition | 2020-06-15 7:40 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 15,060 | $0 | 34,004 (Direct) | View |
| 2020-06-11 Tax Withholding | 2020-06-15 7:39 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer | 9,755 | $3.09 | 42,926 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 7:39 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer | 22,591 | $0 | 42,926 (Direct) | View |
| 2020-06-11 Disposition | 2020-06-15 7:39 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer | 22,591 | $0 | 42,926 (Direct) | View |
| 2020-06-12 Option Award | 2020-06-15 7:38 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin Chief R&D Officer | 16,002 | $0 | 25,792 (Direct) | View |
| 2020-06-12 Disposition | 2020-06-15 7:38 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin Chief R&D Officer | 16,002 | $0 | 25,792 (Direct) | View |
| 2020-06-12 Tax Withholding | 2020-06-15 7:38 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin Chief R&D Officer | 6,211 | $3.46 | 25,792 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:10 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Modig Berndt Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:09 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Pande Atul Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:07 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Torti Frank Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:06 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Sundaram Senthil Vel Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:04 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin EVP of R&D | 106,100 | $0 | 106,100 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:01 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 131,500 | $0 | 131,500 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 8:59 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer | 281,800 | $0 | 281,800 (Direct) | View |